{"id":"W2902672529","doi":"10.1200/jco.18.01624","title":"Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; Centre hospitalier de l'Université Laval; Institute of Cancer Research; Jewish General Hospital","funders":"Daiichi Sankyo Europe; Genentech; Astellas Pharma; Eisai; Cancer Research UK; GlaxoSmithKline; Public Health Agency; MacroGenics; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Genomic Health","keywords":"Letrozole; Palbociclib; Medicine; Breast cancer; Estrogen receptor; Internal medicine; Oncology; Urology; Cancer; Metastatic breast cancer; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01003618,0.0002584928,0.003037972,0.0003465216,0.00007740027,0.00001374103,0.000230912,0.0002949055,0.001080416],"category_scores_gemma":[0.003650106,0.0001876685,0.0004905905,0.0004223569,0.0003316455,0.0002221095,0.00006935349,0.001178228,0.00002503176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005966565,"about_ca_system_score_gemma":0.001951102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003810175,"about_ca_topic_score_gemma":0.0002923522,"domain_scores_codex":[0.9920538,0.002878946,0.003578698,0.0003836477,0.0006869244,0.0004179516],"domain_scores_gemma":[0.9935607,0.003008453,0.002028533,0.0002291822,0.0007859872,0.0003871666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5968614,0.005586331,0.003578897,0.000001782593,0.0003575138,0.0001409627,0.002015172,0.00001957424,0.0006915145,0.00000942425,0.00009838524,0.390639],"study_design_scores_gemma":[0.8181682,0.1622614,0.01589346,0.0002977987,0.0001688255,0.0001014708,0.0009026687,0.00006993795,0.0001381078,0.000369147,0.001477676,0.0001512527],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862159,0.0004356013,0.0001002413,0.008637832,0.001692332,0.002711985,0.00002800372,0.00001315099,0.0001649414],"genre_scores_gemma":[0.9899292,0.0003796982,0.002097246,0.0025364,0.004753292,0.0002057974,0.000005529632,0.00003611048,0.00005670892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3904877,"threshold_uncertainty_score":0.9998327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1484660686979292,"score_gpt":0.5541645440786152,"score_spread":0.405698475380686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}